{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:31:14Z","timestamp":1791192674826,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>BCR-ABL negative myeloproliferative neoplasms (MPNs; polycythemia vera, essential thrombocythemia, primary myelofibrosis) are malignant diseases arising from a multipotent hematopoietic progenitor, frequently altered by JAK2 V617F or other JAK\/STAT activating mutations. The thrombopoietin receptor (TpoR, MPL) is one of the major dimeric cytokine receptors that use JAK2 in the myeloid lineage, and was found to be down-modulated in certain MPN patients. We searched for negative regulators of MPL expression. Here we report that miR-28 targets the 3\u2032 untranslated (3\u2032UTR) region of MPL, inhibiting its translation, as well as other proteins potentially involved in megakaryocyte differentiation, such as E2F6. Expression of miR-28 in CD34-derived megakaryocytes inhibited terminal differentiation. miR-28 was found to be overexpressed in platelets of a fraction of MPN patients, while it was expressed at constant low levels in platelets from healthy subjects. Constitutive activation of STAT5 leading to autonomous growth of hematopoietic cell lines was associated with increased miR-28 expression. We discuss how down-modulating MPL and other targets of miR-28, and of related miR-708 and miR-151, could contribute to MPN pathogenicity.<\/jats:p>","DOI":"10.1182\/blood-2008-06-165985","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T02:44:42Z","timestamp":1273113882000},"page":"437-445","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":115,"title":["miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets"],"prefix":"10.1182","volume":"116","author":[{"given":"Michael","family":"Girardot","sequence":"first","affiliation":[{"name":"Ludwig Institute for Cancer Research Ltd, Brussels, Belgium;"},{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pecquet","sequence":"additional","affiliation":[{"name":"Ludwig Institute for Cancer Research Ltd, Brussels, Belgium;"},{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Boukour","sequence":"additional","affiliation":[{"name":"Inserm, Unit 0790, Institut Gustave Roussy, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Knoops","sequence":"additional","affiliation":[{"name":"Cliniques Universitaires St Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Ferrant","sequence":"additional","affiliation":[{"name":"Cliniques Universitaires St Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[{"name":"Inserm, Unit 0790, Institut Gustave Roussy, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Giraudier","sequence":"additional","affiliation":[{"name":"Inserm, Unit 0790, Institut Gustave Roussy, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Ludwig Institute for Cancer Research Ltd, Brussels, Belgium;"},{"name":"de Duve Institute, Universit\u00e9 Catholique de Louvain, Brussels, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111723043384900_B1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes.","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"issue":"2","key":"2019111723043384900_B2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0308-2261(21)00434-3","article-title":"Analysis of haemopoiesis: the use of cell markers and in vitro culture techniques in studies of clonal haemopathies in man.","volume":"13","author":"Adamson","year":"1984","journal-title":"Clin Haematol"},{"issue":"9464","key":"2019111723043384900_B3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"7037","key":"2019111723043384900_B4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"2019111723043384900_B5","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders.","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111723043384900_B6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111723043384900_B7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111723043384900_B8","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"issue":"10","key":"2019111723043384900_B9","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111723043384900_B10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2005-06-2600","article-title":"An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.","volume":"107","author":"Staerk","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111723043384900_B11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111723043384900_B12","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood-2006-03-008805","article-title":"Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.","volume":"108","author":"Moliterno","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111723043384900_B13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"4551","key":"2019111723043384900_B14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.6177045","article-title":"HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.","volume":"216","author":"Martin","year":"1982","journal-title":"Science"},{"issue":"2","key":"2019111723043384900_B15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/MCB.17.2.695","article-title":"A JAK1\/JAK2 chimera can sustain alpha and gamma interferon responses.","volume":"17","author":"Kohlhuber","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2019111723043384900_B16","first-page":"1031","article-title":"Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, M07e.","volume":"19","author":"Hendrie","year":"1991","journal-title":"Exp Hematol"},{"issue":"3","key":"2019111723043384900_B17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(85)80053-2","article-title":"Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.","volume":"41","author":"Palacios","year":"1985","journal-title":"Cell"},{"issue":"1","key":"2019111723043384900_B18","first-page":"341","article-title":"Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.","volume":"51","author":"Komatsu","year":"1991","journal-title":"Cancer Res"},{"issue":"19","key":"2019111723043384900_B19","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1074\/jbc.M709302200","article-title":"Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2.","volume":"283","author":"Dusa","year":"2008","journal-title":"J Biol Chem"},{"issue":"20","key":"2019111723043384900_B20","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR.","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2019111723043384900_B21","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2103s69","article-title":"Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo.","author":"Aparicio","year":"2005","journal-title":"Curr Protoc Mol Biol"},{"issue":"3","key":"2019111723043384900_B22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V91.3.830","article-title":"Effects of cytokines on platelet production from blood and marrow CD34+ cells.","volume":"91","author":"Norol","year":"1998","journal-title":"Blood"},{"issue":"27","key":"2019111723043384900_B23","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1073\/pnas.0701773104","article-title":"The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch.","volume":"104","author":"Oberst","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111723043384900_B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrm714","article-title":"Sibling rivalry in the E2F family.","volume":"3","author":"Trimarchi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2019111723043384900_B25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/MCB.16.2.685","article-title":"E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes.","volume":"16","author":"Guy","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2019111723043384900_B26","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1128\/MCB.17.9.4991","article-title":"Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.","volume":"17","author":"Rouyez","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2019111723043384900_B27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<344::AID-CNCR14>3.0.CO;2-6","article-title":"Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report.","volume":"88","author":"Fiedler","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"2019111723043384900_B28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2404081","article-title":"JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.","volume":"20","author":"Quentmeier","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"2019111723043384900_B29","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/MCB.18.7.3871","article-title":"Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation.","volume":"18","author":"Onishi","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2019111723043384900_B30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/geno.1996.0432","article-title":"LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family.","volume":"36","author":"Petit","year":"1996","journal-title":"Genomics"},{"issue":"4","key":"2019111723043384900_B31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1043>3.0.CO;2-N","article-title":"An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15).","volume":"29","author":"Rogalla","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2019111723043384900_B32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/gcc.1157","article-title":"Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23).","volume":"31","author":"Dah\u00e9ron","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"2019111723043384900_B33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/shem.2003.50027","article-title":"Etiology of the myeloproliferative disorders: the role of thrombopoietin.","volume":"40","author":"Kaushansky","year":"2003","journal-title":"Semin Hematol"},{"issue":"1","key":"2019111723043384900_B34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.beha.2006.11.005","article-title":"The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age.","volume":"20","author":"Kaushansky","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"9501","key":"2019111723043384900_B35","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"2019111723043384900_B36","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1634\/stemcells.2007-0207","article-title":"E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1.","volume":"25","author":"Kikuchi","year":"2007","journal-title":"Stem Cells"},{"issue":"7","key":"2019111723043384900_B37","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.18.7.4282","article-title":"Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.","volume":"18","author":"Matsumura","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019111723043384900_B38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1182\/blood.V94.4.1273","article-title":"Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.","volume":"94","author":"Rojnuckarin","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2019111723043384900_B39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2141.2009.07597.x","article-title":"The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia.","volume":"145","author":"Lambert","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111723043384900_B40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood-2009-06-227033","article-title":"Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.","volume":"115","author":"Saur","year":"2010","journal-title":"Blood"},{"issue":"29","key":"2019111723043384900_B41","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1074\/jbc.M501376200","article-title":"Janus kinases affect thrombopoietin receptor cell surface localization and stability.","volume":"280","author":"Royer","year":"2005","journal-title":"J Biol Chem"},{"issue":"9","key":"2019111723043384900_B42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets.","volume":"16","author":"Landry","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"2019111723043384900_B43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3324\/haematol.12706","article-title":"Aberrant expression of microRNA in polycythemia vera.","volume":"93","author":"Bruchova","year":"2008","journal-title":"Haematologica"},{"issue":"11","key":"2019111723043384900_B44","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.exphem.2007.08.020","article-title":"MicroRNA expression profile in granulocytes from primary myelofibrosis patients.","volume":"35","author":"Guglielmelli","year":"2007","journal-title":"Exp Hematol"},{"issue":"6","key":"2019111723043384900_B45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.devcel.2008.03.012","article-title":"MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.","volume":"14","author":"Lu","year":"2008","journal-title":"Dev Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/3\/437\/1331908\/zh802910000437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/116\/3\/437\/1331908\/zh802910000437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T05:47:07Z","timestamp":1635313627000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/116\/3\/437\/27602\/miR28-is-a-thrombopoietin-receptor-targeting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-06-165985","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}